Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iRhythm HoldingsIRTC -2.36%79 Equity-to-Asset is 0.17 as of Jun. 2026, which is 67% below its 10-year median of 0.51. GuruFocus rates IRTC with a GF Score™ of 79/100 and a GF Value™ of $153.86 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 854 Medical Devices & Instruments companies, iRhythm Holdings ranks worse than 88.76% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. iRhythm Holdings's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $186.0 Mil. iRhythm Holdings's Total Assets for the quarter that ended in Jun. 2026 was $1,093.4 Mil.
Therefore, iRhythm Holdings's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.17.
The historical rank and industry rank for iRhythm Holdings's Equity-to-Asset or its related term are showing as below:
IRTC'
s Equity-to-Asset Range Over the Past 10 Years
Min: -4.2 Med: 0.51 Max: 0.67
Current: 0.17
During the past 12 years, the highest Equity to Asset Ratio of iRhythm Holdings was 0.67. The lowest was -4.20. And the median was 0.51.
IRTC's Equity-to-Asset is ranked worse than 88.76% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs IRTC: 0.17
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
iRhythm Holdings Equity-to-Asset Related Terms
iRhythm Holdings Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for iRhythm Holdings's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IRTC vs HAE, ITGR, LIVN: Equity-to-Asset Comparison
For the Medical Devices subindustry, iRhythm Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRhythm Holdings Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Holdings's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where iRhythm Holdings's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
iRhythm Holdings's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iRhythm Holdings (IRTC) has a Equity-to-Asset of 0.17 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on iRhythm Holdings and its competitors. This is 67% below median its historical median of 0.51. According to the industry distribution chart, iRhythm Holdings ranks #758 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 88.8%.
Is iRhythm Holdings' Equity-to-Asset too high?
iRhythm Holdings' current Equity-to-Asset of 0.17 is 67% below median its 10-year median of 0.51. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. iRhythm Holdings' value of 0.17 is 73.4% below this industry median. Based on the distribution chart, iRhythm Holdings ranks #758 out of 854 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, iRhythm Holdings has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iRhythm Holdings' Equity-to-Asset compare to HAE and ITGR?
According to the Medical Devices & Instruments industry distribution chart, iRhythm Holdings ranks #758 out of 854 companies for Equity-to-Asset. This places iRhythm Holdings in the lower half of its industry. The industry median Equity-to-Asset is 0.64. iRhythm Holdings' value of 0.17 is 73.4% below this benchmark. While the company's 10-year median is 0.51 vs. the industry median of 0.64, iRhythm Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iRhythm Holdings's current Equity-to-Asset of 0.17 is 73.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on iRhythm Holdings and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iRhythm Holdings's current Equity-to-Asset is 0.17, which is 67% below median its own 10-year median of 0.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRhythm Holdings stock overvalued right now?
Based on GuruFocus' analysis, iRhythm Holdings (IRTC) is currently considered Modestly Undervalued. The stock's GF Value™ is $153.86, compared to a current price of $121.81 — trading 20.8% below its estimated fair value. The current Equity-to-Asset is 0.17, which is 67% below median its 10-year median of 0.51 and 73.4% below the Medical Devices & Instruments industry median of 0.64. iRhythm Holdings' overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For iRhythm Holdings (IRTC), the current Equity-to-Asset is 0.17 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iRhythm Holdings (IRTC) Overvalued in 2026?
Based on GuruFocus' analysis, iRhythm Holdings stock appears to be undervalued.
The current stock price of $121.81 is trading 20.8% below its estimated GF Value™ of $153.86.
GuruFocus considers iRhythm Holdings to be Modestly Undervalued.
Key valuation signals for IRTC:
Equity-to-Asset: 0.17 (67% below median its 10-year median of 0.51)
GF Value™: $153.86 vs. price of $121.81 (20.8% below fair value)
Industry Position: 73.4% below the Medical Devices & Instruments median (#758 of 854)
No single metric tells the full story. See the IRTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
79GF Score
Get the complete analysis for IRTC
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IRTC has been successfully added to your 
